BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25955408)

  • 1. Expression of beclin-1 in the microenvironment of invasive ductal carcinoma of the breast: correlation with prognosis and the cancer-stromal interaction.
    Morikawa A; Takeuchi T; Kito Y; Saigo C; Sakuratani T; Futamura M; Yoshida K
    PLoS One; 2015; 10(5):e0125762. PubMed ID: 25955408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis.
    Zhang K; Corsa CA; Ponik SM; Prior JL; Piwnica-Worms D; Eliceiri KW; Keely PJ; Longmore GD
    Nat Cell Biol; 2013 Jun; 15(6):677-87. PubMed ID: 23644467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer.
    Toy KA; Valiathan RR; Núñez F; Kidwell KM; Gonzalez ME; Fridman R; Kleer CG
    Breast Cancer Res Treat; 2015 Feb; 150(1):9-18. PubMed ID: 25667101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
    Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
    J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A membrane-type-1 matrix metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells.
    Assent D; Bourgot I; Hennuy B; Geurts P; Noël A; Foidart JM; Maquoi E
    PLoS One; 2015; 10(3):e0116006. PubMed ID: 25774665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer.
    Won KY; Kim GY; Kim YW; Song JY; Lim SJ
    Hum Pathol; 2010 Jan; 41(1):107-12. PubMed ID: 19762066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment.
    Sanguinetti A; Santini D; Bonafè M; Taffurelli M; Avenia N
    World J Surg Oncol; 2015 Mar; 13():129. PubMed ID: 25881039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
    Poudel B; Lee YM; Kim DK
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
    Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
    Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
    Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
    Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer.
    Choi J; Jung W; Koo JS
    Histopathology; 2013 Jan; 62(2):275-86. PubMed ID: 23134379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
    Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
    Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discoidin domain receptor 2 mediates the collagen II-dependent release of interleukin-6 in primary human chondrocytes.
    Klatt AR; Zech D; Kühn G; Paul-Klausch B; Klinger G; Renno JH; Schmidt J; Malchau G; Wielckens K
    J Pathol; 2009 Jun; 218(2):241-7. PubMed ID: 19267386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
    Zhang B; Liu FF; Ma YJ; Gu F
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
    Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
    Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
    Badiola I; Villacé P; Basaldua I; Olaso E
    Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discoidin domain receptors: a promoter of the aggressive behavior of ameloblastomas.
    Yang J; Liu J; Zhong M; Chen Y; Song M; Du Y
    IUBMB Life; 2014 Apr; 66(4):292-9. PubMed ID: 24723326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.